Tags

Type your tag names separated by a space and hit enter

Propofol sedation for endoscopic procedures in patients 90 years of age and older.
Digestion. 2008; 78(1):20-3.D

Abstract

BACKGROUND AND AIM

There are only a few studies on propofol sedation for very elderly patients. The present study was undertaken to evaluate the safety of propofol sedation in patients 90 years of age and older undergoing endoscopic procedures.

METHODS

We prospectively assessed endoscopic procedures for patients 90 years of age and older using propofol sedation. Endoscopic procedures, dosage used, respiratory depression, complications and 30-day mortality were evaluated. In a subset of the enrolled patients, the blood concentrations of propofol were measured.

RESULTS

All 241 patients completed endoscopic procedures. For esophagogastroduodenoscopy, percutaneous endoscopic gastrostomy, colonoscopy, and endoscopic retrograde cholangiopancreatography, the mean propofol doses used were 22, 24, 46 and 42 mg, respectively. Four patients required oxygen and 1 patient was treated by short periods of mask ventilation. There was no perforation, bleeding, pancreatitis or 30-day mortality. In diagnostic esophagogastroduodenoscopy, the level of sedation and propofol blood concentrations after administration of propofol (24 +/- 6.8 mg) in patients 90 years of age and older corresponded to those of propofol (61 +/- 13 mg) in middle-aged patients (control).

CONCLUSION

Low-dose propofol sedation is safe and may be enough for patients 90 years of age and older undergoing endoscopic procedures.

Authors+Show Affiliations

Department of Gastroenterology, Showa Inan General Hospital, Komagane, Japan. horiuchi.akira@sihp.jpNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

18765935

Citation

Horiuchi, Akira, et al. "Propofol Sedation for Endoscopic Procedures in Patients 90 Years of Age and Older." Digestion, vol. 78, no. 1, 2008, pp. 20-3.
Horiuchi A, Nakayama Y, Tanaka N, et al. Propofol sedation for endoscopic procedures in patients 90 years of age and older. Digestion. 2008;78(1):20-3.
Horiuchi, A., Nakayama, Y., Tanaka, N., Ichise, Y., Katsuyama, Y., & Ohmori, S. (2008). Propofol sedation for endoscopic procedures in patients 90 years of age and older. Digestion, 78(1), 20-3. https://doi.org/10.1159/000151765
Horiuchi A, et al. Propofol Sedation for Endoscopic Procedures in Patients 90 Years of Age and Older. Digestion. 2008;78(1):20-3. PubMed PMID: 18765935.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Propofol sedation for endoscopic procedures in patients 90 years of age and older. AU - Horiuchi,Akira, AU - Nakayama,Yoshiko, AU - Tanaka,Naoki, AU - Ichise,Yasuyuki, AU - Katsuyama,Yoshihiko, AU - Ohmori,Shigeru, Y1 - 2008/09/02/ PY - 2008/04/30/received PY - 2008/06/30/accepted PY - 2008/9/4/pubmed PY - 2009/2/24/medline PY - 2008/9/4/entrez SP - 20 EP - 3 JF - Digestion JO - Digestion VL - 78 IS - 1 N2 - BACKGROUND AND AIM: There are only a few studies on propofol sedation for very elderly patients. The present study was undertaken to evaluate the safety of propofol sedation in patients 90 years of age and older undergoing endoscopic procedures. METHODS: We prospectively assessed endoscopic procedures for patients 90 years of age and older using propofol sedation. Endoscopic procedures, dosage used, respiratory depression, complications and 30-day mortality were evaluated. In a subset of the enrolled patients, the blood concentrations of propofol were measured. RESULTS: All 241 patients completed endoscopic procedures. For esophagogastroduodenoscopy, percutaneous endoscopic gastrostomy, colonoscopy, and endoscopic retrograde cholangiopancreatography, the mean propofol doses used were 22, 24, 46 and 42 mg, respectively. Four patients required oxygen and 1 patient was treated by short periods of mask ventilation. There was no perforation, bleeding, pancreatitis or 30-day mortality. In diagnostic esophagogastroduodenoscopy, the level of sedation and propofol blood concentrations after administration of propofol (24 +/- 6.8 mg) in patients 90 years of age and older corresponded to those of propofol (61 +/- 13 mg) in middle-aged patients (control). CONCLUSION: Low-dose propofol sedation is safe and may be enough for patients 90 years of age and older undergoing endoscopic procedures. SN - 1421-9867 UR - https://www.unboundmedicine.com/medline/citation/18765935/Propofol_sedation_for_endoscopic_procedures_in_patients_90_years_of_age_and_older_ DB - PRIME DP - Unbound Medicine ER -